CPRX FY 2022 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$214M+52.1% YoY

Gross Profit

$180M83.9% margin

Operating Income

$102M47.5% margin

Net Income

$83M38.8% margin

EPS (Diluted)

$0.75

Cash Flow

Operating Cash Flow

$116M

Free Cash Flow

$116M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$376M

Total Liabilities

$75M

Stockholders' Equity

$300M

Cash & Equivalents

$298M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$214M	$141M	+52.1%
Gross Profit	$180M	$119M	+51.2%
Operating Income	$102M	$52M	+94.4%
Net Income	$83M	$39M	+110.4%